Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(50.0%)
N/A
2(50.0%)
4Total
Phase 4(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05628584Not ApplicableCompleted

High FODMAP Diet With Metformin in preDM

Role: lead

NCT06671340Not ApplicableNot Yet Recruiting

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Role: lead

NCT06838819Not Yet Recruiting

CGM in Icodextrin PD

Role: lead

NCT05218915Phase 4Completed

Basal Plus GLP1-ra on Glycemic Variability in CKD

Role: lead

NCT04776811Completed

Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis

Role: lead

NCT03389490Phase 4Completed

Toujeo Versus NPH Self-titration Study

Role: lead

All 6 trials loaded